List of Excipients in API hyaluronidase
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing hyaluronidase
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| A-S Medication Solutions | HYLENEX RECOMBINANT | hyaluronidase (human recombinant) | 50090-4534 | ALBUMIN HUMAN | |
| A-S Medication Solutions | HYLENEX RECOMBINANT | hyaluronidase (human recombinant) | 50090-4534 | HYDROCHLORIC ACID | |
| A-S Medication Solutions | HYLENEX RECOMBINANT | hyaluronidase (human recombinant) | 50090-4534 | METHIONINE | |
| A-S Medication Solutions | HYLENEX RECOMBINANT | hyaluronidase (human recombinant) | 50090-4534 | POLYSORBATE 80 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for hyaluronidase
Excipient focus: ALBUMIN HUMAN
hyaluronidase drug variants containing ALBUMIN HUMAN
| Company | Ingredient | NDC |
|---|---|---|
| Antares Pharma Inc | hyaluronidase | 18657-117 |
| HF Acquisition Co LLC DBA HealthFirst | hyaluronidase | 51662-1555 |
| A-S Medication Solutions | hyaluronidase (human recombinant) | 50090-4534 |
| >Company | >Ingredient | >NDC |
hyaluronidase drug variants not containing ALBUMIN HUMAN
| Company | Ingredient | NDC |
|---|---|---|
| Amphastar Pharmaceuticals Inc | hyaluronidase | 0548-9090 |
| Bausch & Lomb Incorporated | hyaluronidase, ovine | 24208-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM CHLORIDE
hyaluronidase drug variants containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Amphastar Pharmaceuticals Inc | hyaluronidase | 0548-9090 |
| >Company | >Ingredient | >NDC |
hyaluronidase drug variants not containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Antares Pharma Inc | hyaluronidase | 18657-117 |
| HF Acquisition Co LLC DBA HealthFirst | hyaluronidase | 51662-1555 |
| A-S Medication Solutions | hyaluronidase (human recombinant) | 50090-4534 |
| Bausch & Lomb Incorporated | hyaluronidase, ovine | 24208-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC POTASSIUM PHOSPHATE
hyaluronidase drug variants containing DIBASIC POTASSIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | hyaluronidase, ovine | 24208-002 |
| >Company | >Ingredient | >NDC |
hyaluronidase drug variants not containing DIBASIC POTASSIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Amphastar Pharmaceuticals Inc | hyaluronidase | 0548-9090 |
| Antares Pharma Inc | hyaluronidase | 18657-117 |
| HF Acquisition Co LLC DBA HealthFirst | hyaluronidase | 51662-1555 |
| A-S Medication Solutions | hyaluronidase (human recombinant) | 50090-4534 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
hyaluronidase drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Amphastar Pharmaceuticals Inc | hyaluronidase | 0548-9090 |
| >Company | >Ingredient | >NDC |
hyaluronidase drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Antares Pharma Inc | hyaluronidase | 18657-117 |
| HF Acquisition Co LLC DBA HealthFirst | hyaluronidase | 51662-1555 |
| A-S Medication Solutions | hyaluronidase (human recombinant) | 50090-4534 |
| Bausch & Lomb Incorporated | hyaluronidase, ovine | 24208-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
hyaluronidase drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Antares Pharma Inc | hyaluronidase | 18657-117 |
| HF Acquisition Co LLC DBA HealthFirst | hyaluronidase | 51662-1555 |
| A-S Medication Solutions | hyaluronidase (human recombinant) | 50090-4534 |
| >Company | >Ingredient | >NDC |
hyaluronidase drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Amphastar Pharmaceuticals Inc | hyaluronidase | 0548-9090 |
| Bausch & Lomb Incorporated | hyaluronidase, ovine | 24208-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
hyaluronidase drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | hyaluronidase, ovine | 24208-002 |
| >Company | >Ingredient | >NDC |
hyaluronidase drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Amphastar Pharmaceuticals Inc | hyaluronidase | 0548-9090 |
| Antares Pharma Inc | hyaluronidase | 18657-117 |
| HF Acquisition Co LLC DBA HealthFirst | hyaluronidase | 51662-1555 |
| A-S Medication Solutions | hyaluronidase (human recombinant) | 50090-4534 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHIONINE
hyaluronidase drug variants containing METHIONINE
| Company | Ingredient | NDC |
|---|---|---|
| Antares Pharma Inc | hyaluronidase | 18657-117 |
| HF Acquisition Co LLC DBA HealthFirst | hyaluronidase | 51662-1555 |
| A-S Medication Solutions | hyaluronidase (human recombinant) | 50090-4534 |
| >Company | >Ingredient | >NDC |
hyaluronidase drug variants not containing METHIONINE
| Company | Ingredient | NDC |
|---|---|---|
| Amphastar Pharmaceuticals Inc | hyaluronidase | 0548-9090 |
| Bausch & Lomb Incorporated | hyaluronidase, ovine | 24208-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: MONOBASIC POTASSIUM PHOSPHATE
hyaluronidase drug variants containing MONOBASIC POTASSIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | hyaluronidase, ovine | 24208-002 |
| >Company | >Ingredient | >NDC |
hyaluronidase drug variants not containing MONOBASIC POTASSIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Amphastar Pharmaceuticals Inc | hyaluronidase | 0548-9090 |
| Antares Pharma Inc | hyaluronidase | 18657-117 |
| HF Acquisition Co LLC DBA HealthFirst | hyaluronidase | 51662-1555 |
| A-S Medication Solutions | hyaluronidase (human recombinant) | 50090-4534 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
hyaluronidase drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Antares Pharma Inc | hyaluronidase | 18657-117 |
| HF Acquisition Co LLC DBA HealthFirst | hyaluronidase | 51662-1555 |
| A-S Medication Solutions | hyaluronidase (human recombinant) | 50090-4534 |
| >Company | >Ingredient | >NDC |
hyaluronidase drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Amphastar Pharmaceuticals Inc | hyaluronidase | 0548-9090 |
| Bausch & Lomb Incorporated | hyaluronidase, ovine | 24208-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
hyaluronidase drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Amphastar Pharmaceuticals Inc | hyaluronidase | 0548-9090 |
| Antares Pharma Inc | hyaluronidase | 18657-117 |
| HF Acquisition Co LLC DBA HealthFirst | hyaluronidase | 51662-1555 |
| A-S Medication Solutions | hyaluronidase (human recombinant) | 50090-4534 |
| >Company | >Ingredient | >NDC |
hyaluronidase drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
hyaluronidase drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Antares Pharma Inc | hyaluronidase | 18657-117 |
| HF Acquisition Co LLC DBA HealthFirst | hyaluronidase | 51662-1555 |
| A-S Medication Solutions | hyaluronidase (human recombinant) | 50090-4534 |
| >Company | >Ingredient | >NDC |
hyaluronidase drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Amphastar Pharmaceuticals Inc | hyaluronidase | 0548-9090 |
| Bausch & Lomb Incorporated | hyaluronidase, ovine | 24208-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC
hyaluronidase drug variants containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Antares Pharma Inc | hyaluronidase | 18657-117 |
| HF Acquisition Co LLC DBA HealthFirst | hyaluronidase | 51662-1555 |
| A-S Medication Solutions | hyaluronidase (human recombinant) | 50090-4534 |
| >Company | >Ingredient | >NDC |
hyaluronidase drug variants not containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Amphastar Pharmaceuticals Inc | hyaluronidase | 0548-9090 |
| Bausch & Lomb Incorporated | hyaluronidase, ovine | 24208-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
hyaluronidase drug variants containing SODIUM PHOSPHATE, MONOBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Amphastar Pharmaceuticals Inc | hyaluronidase | 0548-9090 |
| >Company | >Ingredient | >NDC |
hyaluronidase drug variants not containing SODIUM PHOSPHATE, MONOBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Antares Pharma Inc | hyaluronidase | 18657-117 |
| HF Acquisition Co LLC DBA HealthFirst | hyaluronidase | 51662-1555 |
| A-S Medication Solutions | hyaluronidase (human recombinant) | 50090-4534 |
| Bausch & Lomb Incorporated | hyaluronidase, ovine | 24208-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: THIMEROSAL
hyaluronidase drug variants containing THIMEROSAL
| Company | Ingredient | NDC |
|---|---|---|
| Amphastar Pharmaceuticals Inc | hyaluronidase | 0548-9090 |
| >Company | >Ingredient | >NDC |
hyaluronidase drug variants not containing THIMEROSAL
| Company | Ingredient | NDC |
|---|---|---|
| Antares Pharma Inc | hyaluronidase | 18657-117 |
| HF Acquisition Co LLC DBA HealthFirst | hyaluronidase | 51662-1555 |
| A-S Medication Solutions | hyaluronidase (human recombinant) | 50090-4534 |
| Bausch & Lomb Incorporated | hyaluronidase, ovine | 24208-002 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links